Protein Muscle Synthesis Meta-analysis: What the Evidence Says

Quick Answer

Protein Muscle Synthesis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Conversely, conditions such as disuse, aging and chronic disease are associated with the progressive loss of muscle mass, muscle quality and muscle strength, ultimately culminating in sarcopenia - a state characterized by physiological and functional decline. [Kristiansen Jonas Boritz (2026); evidence level 1]
• To this end, a positive net change in muscle mass in response to both dietary stimuli and exercise stimuli is generally believed to be primarily driven by an increase in MPS, while reduced MPS rate rather than increased MPB appears to be the main driver of negative net changes in muscle mass in healthy aged individuals (;;;). [Kristiansen Jonas Boritz (2026); evidence level 1]
• Contemporary diagnostic frameworks established by the European Working Group on Sarcopenia in Older People (EWGSOP) prioritize muscle strength assessment as the cardinal criterion, supplemented by confirmatory evidence of diminished muscle quality or quantity and compromised physical performance. [Dharmansyah Dhika (2026); evidence level 3]
• Emerging evidence establishes sarcopenia as a pivotal modifiable risk factor for falls. [Dharmansyah Dhika (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For protein muscle synthesis meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kristiansen Jonas Boritz (2026). Age-related anabolic resistance and post-absorptive muscle protein synthesis: integrative evidence from a systematic review and meta-analysis. DOI: 10.3389/fphys.2026.1740284. PMCID: PMC13278896. PMID: 42326998. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13278896/
• Dharmansyah Dhika (2026). Exercise and nutritional interventions for sarcopenia-related fall prevention in older adults: An umbrella review. DOI: 10.1016/j.jnha.2026.100862. PMCID: PMC13235354. PMID: 42208412. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13235354/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.